Allergan to pay $600 million to settle Department of Justice probe into Botox marketing

September 2, 2010

Allergan Inc., the maker of wrinkle-smoothing Botox, has agreed to pay $600 million to settle a years long federal investigation into its marketing of the top-selling, botulin-based drug. (GazetteXtra)